Anti-CGRP for Inflamation and Pain Modulation in Small Fiber Neuropathy/Fibromyalgia
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The investigators will treat patients (targeting enrollment of n=20) who suffer from
trigeminal or glossopharyngeal nerve pain in the context of painful small fiber neuropathy.
The primary pain-related objective is reduction of pain and reduced use of rescue and other
anti-pain medications. Another goal is to monitor and confirm the safety profile established
in the migraine population, during previous Phase 3 trials.